BioLargo’s Tonya Chandler to Present with Expert Panel at Sustain SoCal’s Water Solutions 6 Web Conference on August 26, 2021

Westminster, CA – August 25, 2021 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced its participation in Water Solutions 6, the sixth annual water innovation focused conference run by Sustain SoCal, a leading cleantech industry advocacy organization in Southern California (https://sustainsocal.org). The event takes place on August 26, 2021 from 1:30 pm to 5:00 pm Pacific Time.

BioLargo’s Director of Strategic Marketing and Business Development Tonya Chandler will be presenting about recent innovations in water treatment focused on per- and polyfluoroalkyl substances (PFAS), a class of water contaminants of emerging concerns. She will discuss BioLargo’s innovative technology that removes PFAS from water without creating significant PFAS-laden waste, and the company’s plans to offer other new PFAS-related services to customers.  

Water Solutions 6 (WS6) is a virtual-only conference focused on exploring real life strategies and innovations in conservation, reuse, desal, water quality and big data in Southern California and the surrounding region. BioLargo is a Title Sponsor for the event.

Registration for WS6 is open to the public. Followers of BioLargo can register for free using the promo code WS6BLGOCOMP. Register here: https://sustainsocal.org/events/event/water-solutions-6/

Distinguished speakers include:

• Joaquin Esquivel, Chair State Water Resources Board, California Water Board
• John Arena, Business Outreach Manager, Metropolitan Water District
• Duane Cave, Director, Moulton Niguel Water District
• Cristina Ahmadpour, President, Isle Inc
• Michael Thomas, Capital Program Management Unit Manager, Metropolitan Water district
• Don Bunts, Assistant General Manager, Santa Margarita Water District
• Sepi Shirkhani, Associate Engineer, Engineering Services Group, Metropolitan Water District
• Alexander Loucopoulos, Managing Director, Sciens Capital
• Marc Serna, Assistant General Manager, South Coast Water District
• Megan Plumlee, Research Director, Orange County Water District
• Brian Probolsky, President, Moulton Niguel Water District
• Lindsey Stuvick, Water Efficiency Manager, Moulton Niguel Water District
• Mike Hwang, Process Engineer and Technologist, Jacobs
• Tonya Chandler, Director of Strategic Marketing and Business Development, BioLargo, Inc.

Sponsors for the event include:

• Metropolitan Water District of Southern California
• Moulton Niguel Water District
• South Coast Water District
• Los Angeles Cleantech Incubator (LACI)
• BioLargo

 

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

 

Video Interview: BioLargo Discusses Highlights from the Last 12-24 Months and Value Catalysts Moving Forward

 

BioLargo Second Quarterly Report of 2021 Highlights Progress of PFAS Treatment Business and Expanding Engineering Client Base

Westminster, CA – August 17, 2021 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, filed its latest Quarterly Report on Form 10-Q with the SEC yesterday (www.biolargo.com/sec-filings). The company has summarized some of the most important points from the report below.

The company is holding an investor webcast on Tuesday, August 17, 2021, at 8:00 am Pacific / 11:00 am Eastern, at the following link, open to the public: https://www.webcaster4.com/Webcast/Page/2448/42482   

Dennis P. Calvert, President and CEO of BioLargo said, “In the past quarter we made significant advances in the commercialization of our PFAS treatment technology, secured new engineering service contracts,  and advanced multiple new high-value business opportunities that have the potential to accelerate our company’s growth in the coming year.”

Financial highlights from the 10-Q:

• Consolidated revenue for the three months ended June 30, 2021 was $464,000, an 11% increase compared to the second quarter of 2020.
• Continued to reduce debt obligations, including the payoff of $406,000 in convertible debt due in August 2021 through the payment of cash and equity, as reported on Form 8-K filed May 19, 2021. Since December 31, 2019, the company has reduced its debt by over $4 million.
• Other than debt owed by its partially owned subsidiary Clyra Medical Technologies, Inc., only Small Business Association and Paycheck Protection Program (PPP) loans totaling $464,000 ($314,000 of which has been applied for forgiveness), and $50,000 of fixed-price convertible debt (due in 2023) remain on BioLargo’s balance sheet.
• Decreased net loss by 28% compared to the second quarter of 2020.

Commercial, operational, and R&D highlights:

• BioLargo Engineering, Science & Technologies (BLEST) was notified of several important contract awards with the potential to increase the company’s operating cash flow and support the subsidiary’s role of commercializing BioLargo’s patented technologies. Together, the new contracts are worth more than $1.2 million in revenue, most of which will be earned over the next six months.
• Began processing potential-client water with the company’s proprietary PFAS-removal water treatment system (called the “BioLargo AEC”) for a major municipality in Southern California and a federal government agency, with sights set on on-site pilots in the near future.  
• Peer-reviewed paper published about the safety of water treated by BioLargo’s energy-efficient water treatment technology, the AOS. The paper concluded that the levels of disinfection by-products generated by the AOS were comparable to those found in ordinary tap water, bolstering the company’s claims that the AOS is a safe, effective water treatment system.
• Advanced a series of commercial opportunities that include product distribution, partnerships, and projects that company management believes could each generate significant revenue. In each case the company is engaged in contract negotiations and will report more details in the future.

 

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

BioLargo Q2 2021 Earnings Results Webcast and Conference Call Tuesday, August 17, 2021 - 11:00 AM Eastern Time

Westminster, CA – August 11, 2021 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company to host investor webcast and conference call on Tuesday August 17, 2021, at 8:00 am PST / 11:00 am EST, open to the public. A webcast and conference call will be held to review the company’s financial results, discuss recent events, and conduct a question-and-answer session.

The webcast, accompanying presentation materials, and teleconference replay will be made available on the Investor Relations section of BioLargo’s website at biolargo.com/investor-relations. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time to register, download, and install any necessary audio video software.

 

To participate in the live webcast and teleconference:

Webcast Link:	https://www.webcaster4.com/Webcast/Page/2448/42482
Teleconference Domestic:	844-602-0380
Teleconference International:	862-298-0970

 

To watch or listen to a replay of the webcast or teleconference:

 

Webcast Replay Expiration:	Tuesday, August 17, 2022
Teleconference Replay Expiration:	Tuesday, August 31, 2021
Teleconference Replay Domestic:	877-481-4010
Teleconference Replay International:	919-882-2331
Replay Passcode:	42482

 

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

 

BioLargo to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021

WESTMINSTER, CA / ACCESSWIRE / August 9, 2021 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, today announced that it will be presenting at the SNN Network Summer Virtual Event 2021 on Wednesday, August 18 at 10 AM Eastern Time. Dennis P. Calvert, President and CEO of BioLargo, will be presenting about BioLargo’s environmental technologies and answering questions from investors. SNN Incorporated is a global multimedia financial news and publishing company that focuses on market awareness and investor visibility for public and private microcap companies. The company publishes the MicroCap Review magazine and StockNewsNow.com.

To access the live presentation, please use the following information:

SNN Network Summer Virtual Event 2021

Date: Wednesday, August 18, 2021

Time: 10:00 AM Eastern Time (7:00 AM Pacific Time)

Webcast: https://www.webcaster4.com/Webcast/Page/2750/42247

BioLargo develops cleantech innovations for pressing environmental challenges like water contamination, PFAS remediation, air quality control, and more. The company’s dynamic technologies are sustainable, affordable, and high-performance solutions for their target markets, and their team of experienced engineers ensure execution excellence. This is BioLargo’s recipe for strong, sustainable, long-term growth.

To watch BioLargo’s presentation, and if you would like to book a one-on-one investor meeting with BioLargo, register (no cost) here: https://conference.snn.network/signup

One-on-one meetings will be scheduled and conducted via private, secure video conference through the conference event platform.

The SNN Network Summer Virtual Event website is available here: https://conference.snn.network/

If you can’t attend the live presentation, all company presentations “webcasts” will be available directly on the conference event platform on this link under the tab “Agenda”: https://conference.snn.network/agenda

 

About BioLargo

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. See our website at www.BioLargo.com.

About SNN.Network

SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU'RE interested in; find out about investor conferences YOU want to attend - all here on SNN Network.

If you would like to attend the SNN Network Summer Virtual Event 2021, please register here: https://conference.snn.network/signup

Contact:

Name: Dennis P. Calvert      

Phone: 888 400-2863

Address: 14921 Chestnut Street, Westminster CA, 92683

Email: dennis.calvert@biolargo.com

Source: BioLargo, Inc. via SNN Network